What You Should Know
- OpenAI has officially acquired the healthcare technology startup Torch, marking a significant expansion of its ChatGPT Health capabilities.
- The deal, valued at approximately $60M -$100M according to reports, aims to create a "unified medical memory" for AI by consolidating scattered patient data from hospitals, labs, and wearables into a single, context-aware engine.
The "Unified Medical Memory" Pivot: Solving Data Silos
For most patients, medical data is
Read More
Digital Health Funding Hits $14.2B in 2025: A Year of AI Exuberance and Market Bifurcation
What You Should Know:
- If 2024 was a year of correction, 2025 was the year of crystallization. The tremors of innovation have settled into bedrock infrastructure, and the market has responded with a distinct roar.
- Annual funding for U.S. digital health startups climbed to $14.2Bin 2025, a meaningful 35% increase over the previous year, according to Rock Health’s annual year-end report. While we haven't returned to the fever dream of pandemic-era peaks, the data reveals a "new
Read More
Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform
What You Should Know:
- VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure's Halo Intelligence™ platform, an AI-powered clinical decision support system that has already increased tumor sequencing rates by 8x for 30,000 patients.
- Through a partnership with Rales' firm New Bearing, VieCure will implement a world-class business system to modernize community oncology clinics, which treat 80% of U.S. cancer
Read More
NVIDIA and Eli Lilly Launch AI Co-Innovation Lab to Reinvent Drug Discovery
What You Should Know
- NVIDIA and Eli Lilly and Company have announced a historic $1B, five-year investment to launch an AI co-innovation lab in the San Francisco Bay Area.
- Utilizing the NVIDIA BioNeMo platform and the next-generation Vera Rubin architecture, the lab will co-locate top AI engineers with biology experts to build a "continuous learning system" that integrates agentic wet labs with robotic manufacturing and physical AI.
The "Continuous Learning" Framework: Connecting
Read More
Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences
What You Should Know
- Anthropic has officially launched Claude for Healthcare, a suite of HIPAA-ready tools that allow providers and payers to use its latest model, Opus 4.5, for high-stakes medical tasks like prior authorization and claims appeals.
- Simultaneously, the company has significantly expanded Claude for Life Sciences, adding deep integrations with platforms like Medidata and ClinicalTrials.gov to automate clinical trial operations and regulatory submissions.
The Engine:
Read More
Abridge and Availity Partner to Automate Prior Authorization at the Point of Conversation
What You Should Know
- Abridge, the leader in clinical conversational AI, and Availity, the nation’s largest health information network, have launched a first-of-its-kind collaboration to automate prior authorization in real-time.
- By embedding Availity’s FHIR-native Intelligent Utilization Management solution into Abridge’s Contextual Reasoning Engine, the partnership aims to provide clinicians with visibility into coverage requirements and enable payer determinations during the
Read More
HealthEx and Anthropic Partner to Bring Personal Health Records Directly to Claude
What You Should Know
- HealthEx and Anthropic have launched a first-of-its-kind integration that allows Claude Pro and Max users to securely connect their medical records from over 50,000 provider organizations directly to the AI.
- The partnership leverages the federal TEFCA framework and a new Model Context Protocol (MCP) to provide personalized health summaries and lab interpretations while ensuring that sensitive patient data is never used for model training.
Bridging the
Read More
Eli Lilly Taps Chai Discovery’s Frontier AI to Design ‘Computer-Aided’ Biologics
What You Should Know
- Eli Lilly and Company has entered a strategic collaboration with Chai Discovery to deploy frontier AI for the design of novel biologic therapeutics.
- The partnership includes the development of an exclusive, purpose-built AI model trained on Lilly’s proprietary data, leveraging Chai's Chai-2 platform to compress discovery timelines from months to weeks.
The "Zero-Shot" Revolution: Slashing Discovery Timelines
In the world of biologics, antibody design has
Read More
AccurKardia Secures Second FDA Clearance for AccurECG 2.0 to Tackle Cardiac Backlogs
What You Should Know
- AccurKardia has announced its second FDA 510(k) clearance for the AccurECG™ Analysis System (v2.0). This enterprise-grade, cloud-based platform is designed to ingest data from any ECG hardware—including patches and Holters—and deliver fully automated, near real-time interpretation for 13 rhythm classifications with 99% accuracy.
- As cardiac data volumes surge due to the proliferation of wearables, AccurECG 2.0 allows hospitals and independent diagnostic testing
Read More
DiMe Launches Initiative to Scale Trusted AI Care Navigation
What You Should Know
- The Digital Medicine Society (DiMe) has launched a new multi-stakeholder initiative, "Scaling Trusted, High-Impact AI Care Navigation," to accelerate the responsible adoption of AI tools that help patients manage appointments, referrals, and insurance.
- Led by title sponsor Intel and a founding coalition of tech and healthcare leaders, the project will develop open-access resources to ensure AI-enabled care journeys are patient-centered, equitable, and
Read More
